Dr. Paul Singh manages postoperative inflammation and pain with LOTEMAX® SM following combined MIGS & Cataract surgery. Interested in learning more?
Paul Singh, MD
The Eye Centers of Racine & Kenosha
Dr. Paul Singh manages post-operative inflammation and pain with LOTEMAX® SM following combined MIGS & Cataract surgery.
Interested in learning more? Visit www.lotemaxsm.com and www.bausch.com
Related Content:
Cataract TherapeuticsINDICATION
LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.
IMPORTANT SAFETY INFORMATION
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for LOTEMAX® SM.
References:
LOTEMAX is a trademark of Bausch & Lomb Incorporated or its affiliates.
© 2020 Bausch & Lomb Incorporated or its affiliates. LSM.0116.USA.20